| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954932 | International Immunopharmacology | 2018 | 7 Pages |
Abstract
Patients receiving combination immunotherapy are at increased risk of selected all-grade irAEs. Although fatal high-grade irAEs is rare, AEs caused by combination immunotherapy should be recognized promptly in order to avoid more serious complications.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Bo Zhang, Qiong Wu, You Lang Zhou, Xinyu Guo, Jun Ge, Jiaji Fu,